Researchers & Partners

Our vision is to discover, develop and deliver transformational medicines for patients through our internal discovery efforts and innovative collaborations and strategic business development opportunities.

What We're Focused On

What We're Focused On

We concentrate our research and development efforts on our core therapeutic areas, and are pursuing multiple drug platforms for each.
In the Pipeline

In The Pipeline

View the entire pipeline or customize your search by area of disease, development phase or modality.

Investigating Combinations in Cancer Research

Investigating Combinations in Cancer Research


Our Research & Development Team

Our Research & Development Team

Our people are dedicated to unlocking the potential of innovative science. Our curiosity, persistence and desire to solve complex problems allow us to pursue our goal of delivering transformational medicines to patients.
Our Research and Development Facilities

Our Research and Development Facilities

Take a look at the worldwide network of state-of the-art facilities where our discovery and development work happens.


Partnering

Partnering

We actively seek partners with access to cutting-edge science that complements the innovation coming out of our own labs. Our business development team collaborates with R&D and organizations around the world to develop transformational medicines.

Researcher Resources

COVID-19 Investigator Sponsored Research (ISR) Application Process

 

BMS has decided to modify its COVID-19 ISR application process, changing from a rolling submission process to a time-period specific “Request for Proposal (RFP) process”. The submission period will be open from July 27th through August 15th, 2020.

  • The new process will be limited to COVID-19 concepts only.
  • Due to the alliance between Pfizer and BMS, COVID-19 concepts involving apixaban will continue with the existing review processes outside of this RFP.
  • All non COVID-19 proposals will continue their existing processes. 

Click here to review the COVID-19 specific “Areas of Interest”.

For questions and more information, please contact your local BMS Medical Representative. 

Independent Research

Independent Research

Bristol Myers Squibb wishes to advance science through supporting novel, independent research that addresses unmet need surrounding our products and therapeutic areas.

Clinical Trials

Clinical Trials

In 2017, we invested $4.8 billion* in R&D which included the discovery and development of new medicines for patients.

*This non-GAAP amount excludes significant upfront and milestone payments for business development transactions and other specified R&D items. 
Evan Janovitz

Input at Every Stage of Discovery

Evan Janovitz leads a team of veterinary pathologists and allied scientists in the Discovery Toxicology organization.